IL19
Basic information
Region (hg38): 1:206770764-206842981
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the IL19 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 10 | 12 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 33 | 38 | 78 | |||
Total | 0 | 0 | 43 | 40 | 7 |
Variants in IL19
This is a list of pathogenic ClinVar variants found in the IL19 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-206770887-AA-GG | Inflammatory bowel disease | Likely benign (Jun 25, 2021) | ||
1-206770888-A-G | Inflammatory bowel disease • not specified | Benign (Feb 01, 2024) | ||
1-206770891-C-G | Inflammatory bowel disease | Likely benign (Dec 03, 2023) | ||
1-206770892-T-G | Inflammatory bowel disease | Likely benign (Mar 09, 2023) | ||
1-206770901-A-G | Inflammatory bowel disease | Uncertain significance (Aug 27, 2022) | ||
1-206770910-G-T | Inflammatory bowel disease | Likely benign (Jun 05, 2019) | ||
1-206770911-C-A | Inflammatory bowel disease | Uncertain significance (Oct 05, 2022) | ||
1-206770911-C-T | Inflammatory bowel disease | Uncertain significance (Aug 16, 2022) | ||
1-206770913-C-T | Inflammatory bowel disease | Likely benign (Jul 19, 2022) | ||
1-206770914-C-T | Inflammatory bowel disease | Uncertain significance (Oct 01, 2022) | ||
1-206770915-G-A | Inflammatory bowel disease • not specified | Uncertain significance (Dec 06, 2021) | ||
1-206770920-C-T | Inflammatory bowel disease | Uncertain significance (Jun 09, 2020) | ||
1-206770924-G-A | Inflammatory bowel disease | Likely benign (Feb 25, 2022) | ||
1-206770940-G-A | Inflammatory bowel disease | Likely benign (Dec 31, 2023) | ||
1-206770942-T-A | Inflammatory bowel disease | Uncertain significance (Dec 11, 2023) | ||
1-206770949-C-G | Inflammatory bowel disease | Likely benign (Dec 12, 2019) | ||
1-206770951-G-A | Inflammatory bowel disease | Likely benign (Jul 19, 2022) | ||
1-206770953-G-A | Inflammatory bowel disease | Uncertain significance (Feb 27, 2020) | ||
1-206770958-C-T | Inflammatory bowel disease | Likely benign (Jun 08, 2022) | ||
1-206770962-T-C | Inflammatory bowel disease | Uncertain significance (Apr 09, 2022) | ||
1-206770964-C-T | Inflammatory bowel disease | Likely benign (Jul 16, 2023) | ||
1-206770965-G-A | Inflammatory bowel disease | Uncertain significance (Nov 18, 2020) | ||
1-206770965-G-T | Inflammatory bowel disease | Uncertain significance (Aug 15, 2022) | ||
1-206770971-A-C | Inflammatory bowel disease | Uncertain significance (Nov 18, 2023) | ||
1-206770976-T-C | Inflammatory bowel disease | Likely benign (Oct 05, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
IL19 | protein_coding | protein_coding | ENST00000340758 | 6 | 44110 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0000433 | 0.652 | 125736 | 1 | 9 | 125746 | 0.0000398 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.668 | 100 | 121 | 0.829 | 0.00000635 | 1417 |
Missense in Polyphen | 20 | 30.375 | 0.65843 | 459 | ||
Synonymous | 0.299 | 45 | 47.6 | 0.945 | 0.00000288 | 398 |
Loss of Function | 0.863 | 8 | 11.1 | 0.721 | 5.70e-7 | 121 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000704 | 0.0000703 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000982 | 0.0000653 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May play some important roles in inflammatory responses. Up-regulates IL-6 and TNF-alpha and induces apoptosis (By similarity). {ECO:0000250}.;
- Pathway
- Jak-STAT signaling pathway - Homo sapiens (human);Cytokine-cytokine receptor interaction - Homo sapiens (human);JAK-STAT-Core;Signaling by Interleukins;Cytokine Signaling in Immune system;Interleukin-20 family signaling;Immune System;IL23-mediated signaling events
(Consensus)
Recessive Scores
- pRec
- 0.146
Intolerance Scores
- loftool
- 0.483
- rvis_EVS
- 0.5
- rvis_percentile_EVS
- 79.89
Haploinsufficiency Scores
- pHI
- 0.0311
- hipred
- N
- hipred_score
- 0.123
- ghis
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.379
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Il19
- Phenotype
- growth/size/body region phenotype; digestive/alimentary phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); immune system phenotype;
Gene ontology
- Biological process
- apoptotic process;immune response;signal transduction;regulation of signaling receptor activity;negative regulation of low-density lipoprotein particle clearance;cytokine-mediated signaling pathway;interleukin-6 biosynthetic process;reactive oxygen species metabolic process;negative regulation of extrinsic apoptotic signaling pathway;positive regulation of intrinsic apoptotic signaling pathway
- Cellular component
- extracellular region;extracellular space
- Molecular function
- cytokine activity